Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer reported strong mid-stage weight loss trial results for its monthly obesity drug and posted fourth-quarter earnings ...
Crain's New York Business

Pfizer takes small step toward obesity market, but investors question limited trial results

Pfizer signaled some promise in its long-running attempt to develop an anti-obesity drug on Tuesday, but analysts say limited results and missing safety information left Wall Street still uncertain ...
Considerable on MSN

Lilly’s Zepbound seen beating Pfizer injection

Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a ...
WCPO Cincinnati

Pfizer says late-stage trials of its COVID-19 vaccine in children show shots are safe and effective

Pfizer and BioNTech said Monday that late-stage trials of its COVID-19 vaccine in children show that the shots were safe and effective in kids aged between 5 and 11. The results mark a key step in ...